VSTM
VSTM
NASDAQ · Biotechnology

Verastem Inc

$4.86
-0.80 (-14.13%)
As of May 9, 1:48 AM ET ·
Analyst Consensus
Strong Buy
15
Analysts
High
Coverage
Buy 14 93%
Hold 1 7%
Sell 0 0%
Price Target
Analyst Price Target +189.1% upside
Low Target $11.84
Average Target $14.05
High Target $17.49
Current Price $4.86
Current
$4.86
Target
$14.05
$11.84 $14.05 avg $17.49
Scenario Analysis
Bear Case
$11.84
143.6%
Low target
Base Case
$14.05
+189.1%
Avg target
Bull Case
$17.49
+259.9%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$11.25
-56.8% from high
52-Week Low
$4.01
+21.2% from low
Target vs 52W High
$14.05
+24.9% vs high
Next Earnings Report
May 11, 2026
Today
EPS Est: $-0.47
Earnings in today. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 75% $257.58 +27.8%
AMGN
Amgen Inc
Hold 44 48% $190.87 -42.5%
GILD
Gilead Sciences Inc
Strong Buy 39 79% $362.68 +176.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 +2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 38 79% $76.80 -89.3%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 75% $102.31 -65.3%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -19.5%
INSM
Insmed Inc
Strong Buy 28 96% $143.40 +41.5%